261 related articles for article (PubMed ID: 24293574)
21. Pathophysiology of articular chondrocalcinosis--role of ANKH.
Abhishek A; Doherty M
Nat Rev Rheumatol; 2011 Feb; 7(2):96-104. PubMed ID: 21102543
[TBL] [Abstract][Full Text] [Related]
22. Thyroid hormones induce features of the hypertrophic phenotype and stimulate correlates of CPPD crystal formation in articular chondrocytes.
Rosenthal AK; Henry LA
J Rheumatol; 1999 Feb; 26(2):395-401. PubMed ID: 9972975
[TBL] [Abstract][Full Text] [Related]
23. Calcium pyrophosphate dihydrate crystal deposition disease.
Bencardino JT; Hassankhani A
Semin Musculoskelet Radiol; 2003 Sep; 7(3):175-85. PubMed ID: 14593559
[TBL] [Abstract][Full Text] [Related]
24. Inorganic pyrophosphate (PPI) in pathologic calcification of articular cartilage.
Johnson K; Terkeltaub R
Front Biosci; 2005 Jan; 10():988-97. PubMed ID: 15569637
[TBL] [Abstract][Full Text] [Related]
25. Unilateral anterior crossbite induces aberrant mineral deposition in degenerative temporomandibular cartilage in rats.
Zhang M; Wang H; Zhang J; Zhang H; Yang H; Wan X; Jing L; Lu L; Liu X; Yu S; Chang W; Wang M
Osteoarthritis Cartilage; 2016 May; 24(5):921-31. PubMed ID: 26746151
[TBL] [Abstract][Full Text] [Related]
26. The prevalence of and factors related to calcium pyrophosphate dihydrate crystal deposition in the knee joint.
Ryu K; Iriuchishima T; Oshida M; Kato Y; Saito A; Imada M; Aizawa S; Tokuhashi Y; Ryu J
Osteoarthritis Cartilage; 2014 Jul; 22(7):975-9. PubMed ID: 24814686
[TBL] [Abstract][Full Text] [Related]
27. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation.
Liu-Bryan R; Pritzker K; Firestein GS; Terkeltaub R
J Immunol; 2005 Apr; 174(8):5016-23. PubMed ID: 15814732
[TBL] [Abstract][Full Text] [Related]
28. Osteopontin promotes pathologic mineralization in articular cartilage.
Rosenthal AK; Gohr CM; Uzuki M; Masuda I
Matrix Biol; 2007 Mar; 26(2):96-105. PubMed ID: 17123806
[TBL] [Abstract][Full Text] [Related]
29. Calcium pyrophosphate deposition disease: clinical manifestations.
Ferrone C; Andracco R; Cimmino MA
Reumatismo; 2012 Jan; 63(4):246-52. PubMed ID: 22303531
[TBL] [Abstract][Full Text] [Related]
30. Dexamethasone promotes calcium pyrophosphate dihydrate crystal formation by articular chondrocytes.
Fahey M; Mitton E; Muth E; Rosenthal AK
J Rheumatol; 2009 Jan; 36(1):163-9. PubMed ID: 19132782
[TBL] [Abstract][Full Text] [Related]
31. [Calcium pyrophosphate dihydrate-crystal induced arthropathy].
Schneider Internist-Rheumatologe Chefarzt Der Abteilung Für Rheumatologie P; Schneider I
Z Rheumatol; 2004 Feb; 63(1):10-21. PubMed ID: 14991274
[TBL] [Abstract][Full Text] [Related]
32. Transglutaminase contributes to CPPD crystal formation in osteoarthritis.
Heinkel D; Gohr CM; Uzuki M; Rosenthal AK
Front Biosci; 2004 Sep; 9():3257-61. PubMed ID: 15353354
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the effect of transforming growth factor beta 1 on pyrophosphate elaboration from various articular tissues.
Rosenthal AK; McCarty BA; Cheung HS; Ryan LM
Arthritis Rheum; 1993 Apr; 36(4):539-42. PubMed ID: 7681284
[TBL] [Abstract][Full Text] [Related]
34. A histological study of calcium pyrophosphate dihydrate crystal-deposition disease.
Ishikawa K; Masuda I; Ohira T; Yokoyama M
J Bone Joint Surg Am; 1989 Jul; 71(6):875-86. PubMed ID: 2545720
[TBL] [Abstract][Full Text] [Related]
35. The role of calcium crystals and their effect on osteoarthritis pathogenesis.
Stücker S; Bollmann M; Garbers C; Bertrand J
Best Pract Res Clin Rheumatol; 2021 Dec; 35(4):101722. PubMed ID: 34732285
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of nucleotide pyrophosphatase/phosphodiesterase 1: implications for developing a calcium pyrophosphate deposition disease modifying drug.
Danino O; Svetitsky S; Kenigsberg S; Levin A; Journo S; Gold A; Drexler M; Snir N; Elkayam O; Fischer B; Arad U
Rheumatology (Oxford); 2018 Aug; 57(8):1472-1480. PubMed ID: 29688536
[TBL] [Abstract][Full Text] [Related]
37. Upregulated ank expression in osteoarthritis can promote both chondrocyte MMP-13 expression and calcification via chondrocyte extracellular PPi excess.
Johnson K; Terkeltaub R
Osteoarthritis Cartilage; 2004 Apr; 12(4):321-35. PubMed ID: 15023384
[TBL] [Abstract][Full Text] [Related]
38. Cartilage in facet joints of patients with ankylosing spondylitis (AS) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in AS.
Bleil J; Sieper J; Maier R; Schlichting U; Hempfing A; Syrbe U; Appel H
Arthritis Res Ther; 2015 Jul; 17(1):170. PubMed ID: 26123554
[TBL] [Abstract][Full Text] [Related]
39. Investigation of calcium crystals in OA knees.
Fuerst M; Lammers L; Schäfer F; Niggemeyer O; Steinhagen J; Lohmann CH; Rüther W
Rheumatol Int; 2010 Mar; 30(5):623-31. PubMed ID: 19639325
[TBL] [Abstract][Full Text] [Related]
40. The progressive ankylosis gene product ANK regulates extracellular ATP levels in primary articular chondrocytes.
Rosenthal AK; Gohr CM; Mitton-Fitzgerald E; Lutz MK; Dubyak GR; Ryan LM
Arthritis Res Ther; 2013 Oct; 15(5):R154. PubMed ID: 24286344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
